Contemporary Clinical Trials Communications
ISSN 2451-8654 · Elsevier BV · United States · active 1997–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Contemporary Clinical Trials Communications a predatory journal?
Our screening does not flag Contemporary Clinical Trials Communications. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Contemporary Clinical Trials Communications indexed in Scopus or Web of Science?
Per our venue index, Contemporary Clinical Trials Communications appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Contemporary Clinical Trials Communications's impact?
Papers in Contemporary Clinical Trials Communications are cited about 1.6 times each within two years of publication, and Scimago places it in Q2, with an h-index of 41. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Contemporary Clinical Trials Communications open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Nature Machine IntelligenceQ1 · Nature Portfolio
- Cell stem cellQ1 · Elsevier BV
- Nature BiotechnologyQ1 · Nature Portfolio
- Ethics and Information TechnologyQ1 · Springer Science+Business Media
- Academy of Management Learning and EducationQ1 · Academy of Management
- Journal of Marketing EducationQ1 · SAGE Publishing